These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38596791)
1. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study. Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study. Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Lianhua Qingwen Granule and Jingyin Gubiao Prescription in Omicron BA.2 Infection and Hospitalization: A Real-World Study of 56,244 Cases in Shanghai, China. Zhang YJ; Liu GJ; Zhang H; Liu C; Chen ZQ; Xian JS; Song DL; Liu Z; Yang X; Wang J; Zhang Z; Zhang LY; Feng H; Zhang YQ; Tan L Chin J Integr Med; 2024 Jun; ():. PubMed ID: 38910189 [TBL] [Abstract][Full Text] [Related]
4. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects. Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial. Zhan YQ; Chen RF; Zheng QS; Li XW; Liu YN; Mootsikapun P; Chayakulkeeree M; Arttawejkul P; Lan TTN; Liu GG; Lu HZ; Liu QQ; Zhong NS; Yang ZF; Zheng JP J Thorac Dis; 2023 May; 15(5):2859-2872. PubMed ID: 37324081 [TBL] [Abstract][Full Text] [Related]
6. A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants. Dong Y; Zhai W; Fang B; Liu C; Yuan S; Wang Y; Song Q; Li H; Chen B; Cui D; Wang J; Wu Q; Zhou C; Zhou M; Li S; Zhuang X; Xu Q; Zheng Y; Wu Y; Zheng J; Cao M Front Pharmacol; 2022; 13():988524. PubMed ID: 36278166 [No Abstract] [Full Text] [Related]
7. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis. Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293 [TBL] [Abstract][Full Text] [Related]
8. Comparative clinical trial of Langenlianqiao oral liquid and Lianhuaqingwen capsule in the treatment of mild cases of coronavirus disease 2019 (COVID-19). Yang YM; Li QX; Liu YZ; Zhou M J Health Popul Nutr; 2024 Oct; 43(1):158. PubMed ID: 39396047 [TBL] [Abstract][Full Text] [Related]
9. Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases. Shen P; Li J; Tu S; Wu Y; Peng Y; Chen G; Chen C J Ethnopharmacol; 2021 Oct; 278():114220. PubMed ID: 34029640 [TBL] [Abstract][Full Text] [Related]
10. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study. Qiao Y; Xu X; Zhou F; Wang K; Li M; Liu C; Chen Z; Yin P; Shi Y; Wang Y; Liu Q Phytomedicine; 2023 Apr; 112():154690. PubMed ID: 36780823 [TBL] [Abstract][Full Text] [Related]
11. Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial. Zheng JP; Ling Y; Jiang LS; Mootsikapun P; Lu HZ; Chayakulkeeree M; Zhang LX; Arttawejkul P; Hu FY; Truong TNL; Perez RA; Gu X; Sun HM; Jiang JJ; Liu RJ; Ding Z; Zhan YQ; Yang ZF; Guan WJ; Zhong NS Virol J; 2023 Nov; 20(1):277. PubMed ID: 38017515 [TBL] [Abstract][Full Text] [Related]
12. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19. Hong L; He M; Li S; Zhao J Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis. Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study. Lu Y; Zhang M; Yang QQ; Li WJ; Yang K; Hu W; Gao SY; Jiang QL; Lin LK; Cheng H; Sun F Evid Based Complement Alternat Med; 2023; 2023():6028554. PubMed ID: 36846053 [TBL] [Abstract][Full Text] [Related]
15. A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants. Zhang W; Gai X; Wang B; Duan Z; Zhou Q; Dai L; Yan C; Wu C; Fan J; Wang P; Yang P; Bao F; Jing H; Cai C; Song C; Ma Y; Sun Y ERJ Open Res; 2024 May; 10(3):. PubMed ID: 38779041 [TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19. Li L; Wang X; Guo X; Li Y; Song Q; Li A Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820 [TBL] [Abstract][Full Text] [Related]
17. High-quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID-19. Huang N; Li S Phytother Res; 2022 Dec; 36(12):4295-4298. PubMed ID: 35915552 [TBL] [Abstract][Full Text] [Related]
18. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study. Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420 [TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus. Xu P; Yang Z; Du S; Hong Z; Zhong S Front Microbiol; 2022; 13():1035941. PubMed ID: 36504796 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]